This post was originally published on Medscape
You will shortly be re-directed to the publisher's website
Elexacaftor/tezacaftor/ivacaftor have transformed cystic fibrosis treatment but appear to benefit lung transplant candidates of Black race or Hispanic ethnicity less than those of White race.
Medscape Medical News